Cancer Hotspot Panel
Clinical Genetic Test
Help
offered by
GTR Test Accession: Help GTR000597429.1
CANCERINHERITED DISEASENERVOUS SYSTEM ... View more
Last updated in GTR: 2022-03-28
Last annual review date for the lab: 2023-02-06 Past due LinkOut
At a Glance
Drug Response; Prognostic; Risk Assessment; ...
Acute myeloid leukemia; Acquired polycythemia vera; Adenomatous polyposis coli, attenuated; ...
ABL1 (9q34.12), AKT1 (14q32.33), ALK (2p23.2-23.1), APC (5q22.2), ATM (11q22.3), ...
Molecular Genetics - Sequence analysis of select exons: Next-Generation (NGS)/Massively parallel sequencing (MPS)
Any person affected by cancer
Not provided
Not provided
Ordering Information
Offered by: Help
Genome-Nilou Lab
View lab's website
Test short name: Help
CHP
Manufacturer's name: Help
Ion AmpliSeq™ Cancer Hotspot Panel
Specimen Source: Help
Who can order: Help
  • Genetic Counselor
  • Licensed Physician
Test Order Code: Help
CHP
Lab contact: Help
Shahram Savad, PhD, MD, Lab Director
Contact Policy: Help
Post-test email/phone consultation regarding genetic test results and interpretation is provided to patients/families.
Pre-test email/phone consultation regarding genetic test results and interpretation is provided to patients/families.
Test service: Help
Genetic counseling
Informed consent required: Help
Yes
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 45
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 34
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument
Sequence analysis of select exons
Next-Generation (NGS)/Massively parallel sequencing (MPS)
Ion Torrent Proton
Clinical Information
Test purpose: Help
Drug Response; Prognostic; Risk Assessment; Therapeutic management
Target population: Help
Any person affected by cancer
Variant Interpretation:
What is the protocol for interpreting a variation as a VUS? Help
According to ACMG guidelines

Will the lab re-contact the ordering physician if variant interpretation changes? Help
Not provided.
Recommended fields not provided:
Technical Information
Test Platform:
Ion semiconductor sequencing
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
98% detection rate for 5% variant frequency at positions with average sequencing coverage from 1,000X to 4,000X
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
No
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.